Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Intas Pharmaceuticals

    Jump to

    • CCI clears Abu Dhabi Investment Authority's minority stake buy in Intas Pharmaceuticals

    • Exclusive | PE firm ChrysCapital to buy out Capital International's stake in Intas Pharmaceuticals

    • Boutique bank Moelis eyes expansion in India amid M&A boom

    • Intas Pharma becomes most valuable privately held pharma company

    • India Inc's FDI overseas down 57% to $1.82 bn

    • Intas Pharmaceuticals Completes Deal to Acquire Actavis

    • Intas buys Teva's European assets for $764 million

    • Aiming for 90% revenues from formulation business: RPG Life

    • Intas to launch its first biosimilar in US in 9-12 months

    • Temasek completes 10.16% stake purchase in Intas Pharma

    • CCI clears Temasek's 10.16% stake buy in Intas

    • Intas Pharmaceuticals files IPO papers with SEBI

      Intas Pharmaceuticals that engaged in the development, manufacture and marketing of pharmaceutical formulations has filed IPO papers with SEBI.

    • Intas Pharma files DRHP for initial public offering

      The IPO will be made through a public issue of equity shares of Rs 10 each at a premium, to be determined through book building aggregating Rs 225 crore of fresh issue and an offer for sale of 11,621,100 equity shares by Mozart Ltd

    • Intas Pharmaceuticals files DRHP for IPO

      Intas Pharmaceuticals, has filed its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (SEBI) for an initial public offering (IPO) of its equity shares of face value Rs 10 each comprising a fresh issue of equity shares aggregating up to Rs 425 crore and an offer for sale of 5,810,550 equity shares by Mozart Limited.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347